Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $696.15 | Total: $3,480.75 |
| 1 | 10 | $589.68 | Total: $5,896.80 |
| 1 | 25 | $499.59 | Total: $12,489.76 |
| 1 | 50 | $425.88 | Total: $21,294.00 |
| 1 | 100 | $368.55 | Total: $36,855.02 |
Overview
BMS-986141(UDM-003183) is a selective and potent protease-activated receptor-4 (PAR-4) antagonist with oral activity and an IC50 value of 0.4 nM.BMS-98614 exhibits significant antithrombotic effects.
Chemical Properties
| Molecular Formula | C27H23N5O5S2 |
| Molecular Weight | 561.63 |
| CAS Numbers | 1478711-48-6 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O(CC=1N=C(SC1)C2=CC=C(C(N(C)C)=O)C=C2)C3=C4C(OC(=C4)C5=CN6C(=N5)SC(OC)=N6)=CC(OC)=C3 |
Storage and Handling
0C Short Term, -20C Long Term
References
E Scott Priestley, et al. Discovery of Two Novel Antiplatelet Clinical Candidates [BMS-986120 and BMS-986141] That Antagonize Protease-Activated Receptor 4. J Med Chem. 2022 Jul 14;65[13] 8843-8854.